Indicators for Quality Assessment of Hospitalized Ischemic Stroke Patients. A Study of the Efficacy of the Code Stroke in Spain
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 240
- 主要终点
- Recovery rate of the Intravenous trombolysis treatment
研究概览
简要总结
Code Stroke is a system for the rapid identification, pre-notification and transport of acute ischemic stroke patients. The objective of this study was to define quality indicators and to compare treatment outcomes in hospitals where Code Stroke has been implemented and hospitals without the use of Code Stroke (control patients).
详细描述
In a first step qualitative technique has been conducted to define treatment quality indicators of acute ischemic stroke patients. In a second step a prospective study is conducted to collect data of 240 inpatients from two groups of hospitals. Two hospitals applying Code Stroke (N= 120) and four hospitals non-applying Code Stroke procedure (N=120). A consecutive sampling method will be conducted. Inclusion criteria: acute ischemic stroke patients treated in the hospitals during the field study. The referral to the hospital could be from primary care, Emergency Unit of other hospital. Patients will enroll after inform consent.
A Singer-blind- research method will applied. Quality indicators defined in the first phase will be applied and comparisons will be realized using ANOVA.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- Single (Investigator)
入排标准
- 年龄范围
- 18 Years 至 100 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •acute ischemic stroke in-patients
排除标准
- •Patients who refuse participate
研究组 & 干预措施
Group A
Hospital using Code Stroke
干预措施: Code Stroke (Procedure)
Group B
Hospital not using Code Stroke
结局指标
主要结局
Recovery rate of the Intravenous trombolysis treatment
时间窗: 1 month
Number of patients showing an adequate recovery after Intravenous trombolysis treatment as assessed by the criteria of the Quality Indicator Board of the German Stroke Registers Study Group and the National Sentinel Audit of Stroke.
次要结局
- Patient satisfaction(1 month)
- Mortality rates of the Intravenous trombolysis treatment(1 month)
- Treatment adequacy: Intravenous trombolysis treatment(1 month)
- Patient engage(1 month)
- response capacity(1 day)
- Patient safety. Complications in the recombinant tissue plasminogen activator treatment after tromobysis(1 month)
研究者
José Joaquín Mira
Professor
Universidad Miguel Hernandez de Elche